International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,544,827
Fulltext
1,050,524
PDF
494,303

Articles	Fulltext downloads	PDF downloads	Total downloads
Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	30,418	3,283	33,701
Short Communication Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	27,871	2,140	30,011
Review Article Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	26,457	2,005	28,462
Editorial Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	26,310	2,017	28,327
Original Article *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	23,253	2,002	25,255
Case Report Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	22,473	1,497	23,970
Review Article Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	20,010	2,695	22,705
Short Communication Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	15,416	2,213	17,629
News Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	12,926	4,468	17,394
Review Article Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	15,163	2,185	17,348
Editorial High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	15,626	1,702	17,328
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	15,368	1,896	17,264
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	15,409	1,752	17,161
Review Article Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	12,006	5,106	17,112
Case Report Spectrum of lymphomas in India Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023	15,791	1,308	17,099
Original Article Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	14,382	1,938	16,320
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	13,937	1,889	15,826
Case Report Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	13,984	1,721	15,705
Review Article Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	11,753	3,852	15,605
Cardio Oncology with ACOS Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	13,741	1,820	15,561
New Drug Update Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,462	1,037	15,499
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	14,643	810	15,453
Review Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	11,107	3,931	15,038
Original Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	10,499	4,108	14,607
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	11,559	3,019	14,578
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	10,388	3,937	14,325
Review Article Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	12,095	2,190	14,285
Case Series Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	8,890	4,874	13,764
Review Article L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	12,561	1,202	13,763
Case Report The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,526	2,158	13,684
Review Article Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,491	6,889	13,380
Editorial Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	10,849	2,520	13,369
Case Report Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	10,452	2,901	13,353
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	10,977	2,354	13,331
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	9,730	3,187	12,917
Review Article Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	8,210	4,655	12,865
Case Report 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	11,102	1,707	12,809
Conference Review ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,477	2,328	12,805
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	8,855	3,936	12,791
Brief Commentary Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,389	1,305	12,694
Erratum Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	10,818	1,862	12,680
Case Report Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	9,891	2,296	12,187
Brief Commentary The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	9,428	2,672	12,100
Review Article Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	8,129	3,966	12,095
Letter to editor Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	6,969	5,026	11,995
Case Report Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	7,626	4,337	11,963
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	6,652	5,225	11,877
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	8,209	3,565	11,774
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	6,126	5,550	11,676
Review Article Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019	5,502	5,874	11,376

Most Viewed Articles

Driver mutations in oncogenesis

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Challenging conventional wisdom in molecular oncology: New perspectives

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Editorial board tribute to Dr. Amit Verma

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

Understanding immunotherapy and CAR-T-cells: A narrative review

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Spectrum of lymphomas in India

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Immune dynamics of SARS-CoV-2 virus evolution

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Advances in immunotherapy for metastatic esophageal cancer

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Immuno-oncological era of breast cancer: A progressive path to better treatment

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Nanobytes

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Immuno-oncology of differentiated thyroid cancer

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

A compendium of population wide DNA methylation profile for oral cancer in India

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

Breast cancer prognostic tools: A promising Indian option

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

The Cancer Genomic Atlas – “TO CONQUER CANCER”

Letter to editor

Metastatic endometrial carcinoma responsive to pembrolizumab

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Molecular genetics changes in gallbladder carcinoma

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**